MARCHF10
protein-codingmembrane associated ring-CH-type finger 10, the group of Membrane associated ring-CH-type fingers|Ring finger proteins
Gene summary
MARCH10 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). MARCH enzymes add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their vesicular transport between membrane compartments (Morokuma et al., 2007 [PubMed 17604280]).[supplied by OMIM, Apr 2010]
- RNF190
- MARCH10
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~107.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MARCHF10 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_152598.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 5 | 11 | ||
| missense | 99 | 15 | 8 | 122 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 102 | 20 | 13 | 135 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_689811.2 | 10 | MANE Select | |
| Ensembl | ENSP00000311496.5 | 10 | MANE Select | |
| RefSeq | NP_001094345.1 | 10 | Standard | |
| RefSeq | NP_001275708.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein ubiquitination
Molecular Function
- protein binding
- zinc ion binding
- transferase activity
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000311269
- Coding exons
- 10
- Length
- 107031
- Individuals with no LoFs
- 125594
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 153
- Defined
- 125748
- p
- 0.000613
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.702 | 374 | 414 | 0.903 | 0.0000214 | 5319 |
| Missense (PolyPhen) | 61 | 77.306 | 0.78907 | 1059 | ||
| Synonymous | -0.755 | 176 | 164 | 1.08 | 0.00000935 | 1528 |
| Loss of Function | -0.269 | 35 | 33.3 | 1.05 | 0.00000162 | 433 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.0061 | 0.0057 | notable |
| Finnish | 0.00024 | 0.00023 | rare |
| European (Non-Finnish) | 0.00021 | 0.00020 | rare |
| South Asian | 0.00030 | 0.00029 | rare |
| Other | 0.00084 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase (Probable). E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. {ECO:0000305}.;
Intolerance Scores
- LoFtool
- 0.971
- RVIS EVS
- 1.8
- RVIS percentile EVS
- 96.94
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0392
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |